Developer of antibody-drug conjugate cancer therapy designed to merge antibodies' efficacy with the potency of small-molecule anticancer drugs. The company's precision medicines are meticulously craft...

Healthcare
New York, NY, United States
Founded 2019
7 employees
Website
Valuation
$53M
Market implied
Share Price
N/A
Total Raised
$6.3M
Last Round
N/A

Get the full picture

Create a free account to unlock Medicovestor's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required